Siraj Ali

Siraj Ali is vice president of clinical development at EQRx, a company committed to making innovative medicines at dramatically lower prices for the benefit of people and society. Previously, he led a translational research group at Foundation Medicine, a cancer genomics company. Siraj has co-authored >200 peer-reviewed publications in precision oncology and cancer biology. He is a graduate of the M.D.-Ph.D. program from Harvard Medical School and completed residency training at the Beth Israel Deaconess Medical Center/Harvard Medical School in Boston and is board-certified in Anatomic Pathology.